切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2022, Vol. 16 ›› Issue (01) : 42 -45. doi: 10.3877/cma.j.issn.1674-0793.2022.01.008

论著

经肛门与腹腔镜全直肠系膜切除术治疗低位直肠癌的应用对比研究
雒洪志1,(), 孙浩1, 钟思权1, 符柏菡2   
  1. 1. 528400 中山市人民医院肿瘤外科
    2. 999078 澳门科技大学中药质量研究所
  • 收稿日期:2021-08-06 出版日期:2022-02-01
  • 通信作者: 雒洪志
  • 基金资助:
    中山市社会公益科技研究项目(2019B1068)

Comparison of transanal and laparoscopic total mesorectal excision in the treatment of low rectal cancer

Hongzhi Luo1,(), Hao Sun1, Siquan Zhong1, Baihan Fu2   

  1. 1. Department of Oncological Surgery, Zhongshan People's Hospital, Zhongshan 528403, China
    2. Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau 999078, China
  • Received:2021-08-06 Published:2022-02-01
  • Corresponding author: Hongzhi Luo
引用本文:

雒洪志, 孙浩, 钟思权, 符柏菡. 经肛门与腹腔镜全直肠系膜切除术治疗低位直肠癌的应用对比研究[J/OL]. 中华普通外科学文献(电子版), 2022, 16(01): 42-45.

Hongzhi Luo, Hao Sun, Siquan Zhong, Baihan Fu. Comparison of transanal and laparoscopic total mesorectal excision in the treatment of low rectal cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2022, 16(01): 42-45.

目的

对比经肛门全直肠系膜切除术(TaTME)与传统腹腔镜全直肠系膜切除术(LaTME)两种术式在低位直肠癌治疗中的病理特征和临床治疗效果。

方法

回顾性分析2015年1月至2020年9月中山市人民医院收治的100例低位直肠癌患者,根据治疗方式被分为TaTME组(接受TaTME)和LaTME组(接受LaTME),每组50例。所有手术切除标本均进行组织病理学检查。术后随访1年,统计分析两组相关指标差异:环周切缘阳性率(CRM+)、远端切缘阳性率(DRM+)、淋巴结阳性率,平均手术时间、出血量、住院时间、肠道功能恢复时间,保肛率和吻合口瘘发生率。

结果

患者均手术顺利,TaTME组的CRM+、DRM+分别为(10±2)%、(8±4)%,与LaTME组的(8±2)%、(6±1)%相比,差异无统计学意义。TaTME组的淋巴结检测阳性率(80±6)%,高于LaTME组的(60±8)%(P=0.041)。TaTME组的平均手术时间(160±35)min和保肛率(80±10)%,均高于LaTME组的(120±26)min、(40±8)%(P<0.001)。TaTME组术中出血量、住院时间、肠道功能恢复时间均低于LaTME组(P<0.001),术后随访1年TaTME组吻合口瘘发生率低于LaTME组(P=0.043)。

结论

TaTME在低位直肠癌患者的治疗中具有显著优势,相对于LaTME可显著提高保肛率,降低并发症的发生。

Objective

To compare the differences of the pathological features and the clinical-therapeutic effects of transanal total mesorectal excision (TaTME) and traditional laparoscopic total mesorectal excision (LaTME) techniques among low rectal cancer patients.

Methods

One hundred low rectal cancer inpatients treated in Zhongshan People' s Hospital were allocated into two groups randomly according to the treatment types: TaTME group (50 cases, adopted TaTME technique) and LaTME group (50 cases, adopted LaTME technique). All surgical specimens were examined histopathologically. After 1 year follow-up, the relevant indexes between the two groups were statistically analyzed: the positive rate of circumferential margin (CRM+), distal margin (DRM+), and lymph nodes; the average operation time, total blood loss, length of hospital stay, recovery time of intestinal function, rate of anus preservation, and the incidence of anastomotic leakage.

Results

All operations went successfully. CRM+ and DRM+ in TaTME group and LaTME group were (10±2)% and (8±4)%, (8±2)% and (6±1)%, respectively, with no significant differences. The positive rate of lymph node detection in TaTME group was (80±6)%, which was higher than (60±8)% in LaTME group (P=0.041). The average operation time and anus preserving rate of TaTME group were (160±35) min, (80±10)%, which were higher than (120±26) min and (40±8)% of LaTME group (P<0.001). The total blood loss, length of hospital stay, recovery time of intestinal function and the incidence of anastomotic leakage in TaTME group were lower than those in LaTME group (P<0.05).

Conclusions

TaTME has significant advantages in the treatment of low rectal cancer. Compared with LaTME, TaTME can significantly improve the anal preservation rate and reduce the incidence of complications.

表1 两组直肠癌根治术患者临床资料及手术指标比较(±s
图1 手术体位以及穿刺孔位置示意图(据《腹腔镜手术学》复旦大学出版社自绘) 脐下10 mm穿刺孔为观察孔(A),右侧骨中线平脐下3 cm及右腋前线脐上3~4 cm处穿刺孔为主操作孔(B、C),左锁骨中线平脐下3 cm及左腋前线肋缘下穿刺孔为辅操作孔(D、E)
图2 腹腔和盆腔操作图片 A为离断肠系膜下静脉;B为离断肠系膜下动脉;C为使用腔镜下直线切割闭合器离断直肠;D为底钉座与吻合器对合,激发完成吻合
图3 直视下连续缝合完成消化道重建
[1]
Heald RJ. A new solution to some old problems: transanal TME[J]. Tech Coloproctol, 2013, 17(3): 257-258.
[2]
张忠涛,郑民华,姚宏伟, 等. 直肠癌经肛全直肠系膜切除专家共识及手术操作指南[J]. 中国实用外科杂志, 2017, 37(9): 978-984.
[3]
Condorelli DF, Privitera AP, Barresi V. Chromosomal density of cancer up-regulated genes, aberrant enhancer activity and cancer fitness genes are associated with transcriptional cis-effects of broad copy number gains in colorectal cancer[J]. Int J Mol Sci, 2019, 20(18): 4652.
[4]
Sylla P, Rattner DW, Delgado S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance[J]. Surg Endosc, 2010, 24(5): 1205-1210.
[5]
Zhang H, Zhang YS, Jin XW, et al. Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer[J]. Tech Coloproctol, 2013, 17(1): 117-123.
[6]
康亮,汪建平. 经肛直肠癌全直肠系膜切除术实践与策略[J/CD]. 中华普外科手术学杂志(电子版), 2016, 10(2): 101-104.
[7]
Deijen CL, Velthuis S, Tsai A, et al. COLOR: A multicentre rando-mised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer[J]. Surg Endosc, 2016, 30(8): 3210-3215.
[8]
王波. 腹腔镜辅助经肛直肠全系膜切除术治疗超低位直肠癌的疗效及安全性分析[J/CD]. 中华普通外科学文献(电子版), 2020, 14(3): 226-229.
[9]
Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: A systematic review and Meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision[J]. BMC Cancer, 2016, 16: 380.
[10]
梁海峰,成敏敏,刘有生. 经肛门全直肠系膜切除和腹腔镜全直肠系膜切除对直肠癌的疗效对比[J/CD]. 中华普通外科学文献(电子版), 2019, 13(2): 125-129.
[11]
Dittrich L, Biebl M, Schmuck R, et al. Initial experience with the safe implementation of transanal total mesorectal excision (TaTME) as a standardized procedure for low rectal cancer[J]. J Clin Med, 2020, 10(1): 72.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要